| COVID-19 infection and rheumatoid arthritis: Faraway, so close! EG Favalli, F Ingegnoli, O De Lucia, G Cincinelli, R Cimaz, R Caporali Autoimmunity reviews 19 (5), 102523, 2020 | 571 | 2020 |
| Mapping and predicting mortality from systemic sclerosis M Elhai, C Meune, M Boubaya, J Avouac, E Hachulla, A Balbir-Gurman, ... Annals of the rheumatic diseases 76 (11), 1897-1905, 2017 | 550 | 2017 |
| Rheumatoid factors: clinical applications F Ingegnoli, R Castelli, R Gualtierotti Disease markers 35 (6), 727-734, 2013 | 383 | 2013 |
| Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis V Smith, AL Herrick, F Ingegnoli, N Damjanov, R De Angelis, CP Denton, ... Autoimmunity reviews 19 (3), 102458, 2020 | 295 | 2020 |
| Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis N Del Papa, G Colombo, N Fracchiolla, LM Moronetti, F Ingegnoli, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 219 | 2004 |
| Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE … F Ingegnoli, P Boracchi, R Gualtierotti, C Lubatti, L Meani, L Zahalkova, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 181 | 2008 |
| Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus N Ronda, E Favari, MO Borghi, F Ingegnoli, M Gerosa, C Chighizola, ... Annals of the rheumatic diseases 73 (3), 609-615, 2014 | 179 | 2014 |
| Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database F Ingegnoli, I Ardoino, P Boracchi, M Cutolo, P Airò, LP Ananieva, ... Microvascular research 89, 122-128, 2013 | 166 | 2013 |
| Ear, nose and throat manifestations of Churg-Strauss syndrome A Bacciu, S Bacciu, G Mercante, F Ingegnoli, C Grasselli, A Vaglio, ... Acta oto-laryngologica 126 (5), 503-509, 2006 | 158 | 2006 |
| Stromal cell–derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID mice MC Blades, F Ingegnoli, SK Wheller, A Manzo, S Wahid, GS Panayi, ... Arthritis & Rheumatism 46 (3), 824-836, 2002 | 150 | 2002 |
| An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases V Smith, S Beeckman, AL Herrick, S Decuman, E Deschepper, ... Rheumatology 55 (5), 883-890, 2016 | 149 | 2016 |
| Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-α blockade F Ingegnoli, F Fantini, EG Favalli, A Soldi, S Griffini, V Galbiati, PL Meroni, ... Journal of autoimmunity 31 (2), 175-179, 2008 | 144 | 2008 |
| Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis F Ingegnoli, N Ughi, C Mihai Best Practice & Research Clinical Rheumatology 32 (2), 223-240, 2018 | 136 | 2018 |
| Nailfold capillary patterns in healthy subjects: a real issue in capillaroscopy F Ingegnoli, R Gualtierotti, C Lubatti, C Bertolazzi, M Gutierrez, P Boracchi, ... Microvascular Research 90, 90-95, 2013 | 131 | 2013 |
| Incidence of COVID‐19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data? EG Favalli, S Monti, F Ingegnoli, S Balduzzi, R Caporali, C Montecucco Arthritis & rheumatology 72 (10), 1600-1606, 2020 | 128 | 2020 |
| Improving outcome prediction of systemic sclerosis from isolated Raynaud’s phenomenon: role of autoantibodies and nail-fold capillaroscopy F Ingegnoli, P Boracchi, R Gualtierotti, EM Biganzoli, S Zeni, C Lubatti, ... Rheumatology 49 (4), 797-805, 2010 | 127 | 2010 |
| Nailfold capillaroscopy in systemic lupus erythematosus: a systematic review and critical appraisal M Cutolo, K Melsens, S Wijnant, F Ingegnoli, K Thevissen, F De Keyser, ... Autoimmunity reviews 17 (4), 344-352, 2018 | 125 | 2018 |
| What is the true incidence of COVID-19 in patients with rheumatic diseases? EG Favalli, F Ingegnoli, R Cimaz, R Caporali Annals of the rheumatic diseases 80 (2), e18-e18, 2021 | 122 | 2021 |
| Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds G Marfia, SE Navone, C Di Vito, N Ughi, S Tabano, M Miozzo, ... Organogenesis 11 (4), 183-206, 2015 | 121 | 2015 |
| Fast track algorithm: how to differentiate a “scleroderma pattern” from a “non-scleroderma pattern” V Smith, A Vanhaecke, AL Herrick, O Distler, MG Guerra, CP Denton, ... Autoimmunity reviews 18 (11), 102394, 2019 | 120 | 2019 |
